Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:INFI

Infinity Pharmaceuticals (INFI) Stock Price, News & Analysis

Infinity Pharmaceuticals logo

About Infinity Pharmaceuticals Stock (NASDAQ:INFI)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.01
$0.13
52-Week Range
N/A
Volume
2.48 million shs
Average Volume
2.58 million shs
Market Capitalization
$726 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive INFI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Infinity Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

INFI Stock News Headlines

The Fed Just Got Kneecapped — Here’s What Happens Next
Donald Trump has done it again! This time, with the signing of the highly controversial new law S.1582 — he’s kneecapped the Federal Reserve…tc pixel
Woman shot while driving in South Memphis
See More Headlines

INFI Stock Analysis - Frequently Asked Questions

Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) announced its quarterly earnings data on Tuesday, November, 2nd. The biotechnology company reported ($0.12) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.14) by $0.02. The biotechnology company earned $0.43 million during the quarter, compared to analysts' expectations of $0.45 million.

Based on aggregate information from My MarketBeat watchlists, some other companies that Infinity Pharmaceuticals investors own include Digital Turbine (APPS), ChargePoint (CHPT), CrowdStrike (CRWD), Vuzix (VUZI) and Sangamo Therapeutics (SGMO).

Company Calendar

Last Earnings
11/02/2021
Today
9/15/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:INFI
CIK
1113148
Employees
30
Year Founded
2000

Profitability

EPS (Trailing Twelve Months)
($0.46)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$44.37 million
Net Margins
-1,593.93%
Pretax Margin
-1,593.93%
Return on Equity
N/A
Return on Assets
-113.02%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.65
Quick Ratio
1.65

Sales & Book Value

Annual Sales
$2.59 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.21) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
90,760,000
Free Float
81,857,000
Market Cap
$726 thousand
Optionable
Optionable
Beta
1.63

Social Links

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:INFI) was last updated on 9/16/2025 by MarketBeat.com Staff
From Our Partners